Currently there is no description available for Annelies Wilder-Smith.
“We do not know the efficacy at this point and that is why we are eagerly awaiting the phase-three trial results. Probably the first two vaccines will come at around the same time and then new additional vaccines will come out. The intent is that by the end of 2021, we would have two billion doses of vaccine that would be fairly distributed to countries around the world.”
26 Oct 2020
4
2
Read More
